You are here

Article info

Article menu

Download PDFPDF

Therapeutics/Prevention
Randomised controlled trial
Cannabinoids fail to show evidence of slowing down the progression of multiple sclerosis
Free

Authors

  1. Correspondence to : Dr Gareth Pryce, Centre for Neuroscience, Blizard Institute, Barts and The London School of Medicine and Dentistry, QMUL, 4 Newark Street, London E1 2AT, UK; g.pryce{at}qmul.ac.uk
View Full Text

Citation

Pryce G, Baker D
Cannabinoids fail to show evidence of slowing down the progression of multiple sclerosis
BMJ Evidence-Based Medicine 2015;20:124.

Publication history

  • First published April 20, 2015.
Online issue publication 
November 05, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions